EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

Construction and validation of an anoikis-related prognostic model for lung adenocarcinoma based on bulk and single-cell transcriptomic data

Yanfeng Xue, Yao Wang, Tianhao Huang, Yingjun Dong, Xin Tong iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0335788 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift PLOS One, 2025. Verfasst von Yanfeng Xue und 4 weiteren Autor:innen. Beteiligte Einrichtung: Shanxi Province Cancer Hospital, Taiyuan, Shanxi Province, China. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Anoikis, Lung Neoplasms, Transcriptome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung adenocarcinoma (LUAD) is a highly aggressive lung cancer with poor prognosis due to lack of reliable biomarkers. Resistance to anoikis drives tumor progression and metastasis. This study aims to develop and validate an anoikis-related prognostic model for LUAD. We employed univariate Cox regression analysis, LASSO regression, and random forest algorithms to identify anoikis-related genes (ARG) from bulk transcriptomic datasets, and establish a 7-gene prognostic signature, validated in two LUAD cohorts from GEO database. We evaluated immune infiltration, molecular functions, and genomic alterations between risk groups and analyzed single-cell RNA sequencing data. IHC and mIF validated TIMP1 expression and its interaction with Treg cells. We developed a 7-gene prognostic model (LDHA, PLK1, TRAF2, ITGB4, SLCO1B3, TIMP1, ZEB2) using machine learning to predict survival in LUAD patients. The model accurately predicted 1-year survival rates (GSE31210: AUC = 0.805; GSE30219: AUC = 0.787), 2-year survival rates (GSE31210: AUC = 0.769; GSE30219: AUC = 0.681), and 3-year survival rates (GSE31210: AUC = 0.695; GSE30219: AUC = 0.735) and correlated with clinical features, immune infiltration, and tumor microenvironment (TME) remodeling. Single-cell sequencing data showed that LUAD patients exhibited an immunosuppressive TME phenotype, which was exacerbated by high TIMP1 expression in epithelial cells, promoting Treg cell activity. The 7-gene ARG prognostic model established in this study shows promising potential as a clinically applicable tool for decision-making.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungAnoikisLung NeoplasmsTranscriptomeHumansPrognosisSingle-Cell AnalysisFemaleMaleBiomarkers, TumorGene Expression Regulation, NeoplasticGene Expression ProfilingMiddle AgedTumor MicroenvironmentAged

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Shanxi Province Cancer Hospital, Taiyuan, Shanxi Province, China.
  • Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Taiyuan, Shanxi Province, China.
  • Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi Province, China.
  • Shanghai Institute of Measurement and Testing Technology Co., Ltd., Shanghai, China.
  • The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China.

ORCID-Profile: Xin Tong

Zitieren

APA

Xue, Y., Wang, Y., Huang, T., Dong, Y., & Tong, X. (2025). Construction and validation of an anoikis-related prognostic model for lung adenocarcinoma based on bulk and single-cell transcriptomic data. PLOS One. https://doi.org/10.1371/journal.pone.0335788

Vancouver

Xue Y, Wang Y, Huang T, Dong Y, Tong X. Construction and validation of an anoikis-related prognostic model for lung adenocarcinoma based on bulk and single-cell transcriptomic data. PLOS One. 2025. doi:10.1371/journal.pone.0335788

BibTeX
@article{Xue2025,
  author = {Xue, Yanfeng and Wang, Yao and Huang, Tianhao and Dong, Yingjun and Tong, Xin},
  title = {Construction and validation of an anoikis-related prognostic model for lung adenocarcinoma based on bulk and single-cell transcriptomic data},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0335788}
}
Kostenlos starten →